vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Perfect Moment Ltd. (PMNT). Click either name above to swap in a different company.

Perfect Moment Ltd. is the larger business by last-quarter revenue ($11.7M vs $7.8M, roughly 1.5× CRYO CELL INTERNATIONAL INC). Perfect Moment Ltd. runs the higher net margin — 0.8% vs -48.7%, a 49.5% gap on every dollar of revenue. On growth, Perfect Moment Ltd. posted the faster year-over-year revenue change (0.8% vs -2.3%). Perfect Moment Ltd. produced more free cash flow last quarter ($2.2M vs $1.2M).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Perfect Moment Ltd is a premium lifestyle and outdoor apparel brand specializing in high-performance, fashionable winter sports gear including ski wear, activewear, and supporting accessories. It serves luxury outdoor and winter sports consumer groups, with sales networks covering core markets in North America, Europe, and the Asia Pacific region.

CCEL vs PMNT — Head-to-Head

Bigger by revenue
PMNT
PMNT
1.5× larger
PMNT
$11.7M
$7.8M
CCEL
Growing faster (revenue YoY)
PMNT
PMNT
+3.0% gap
PMNT
0.8%
-2.3%
CCEL
Higher net margin
PMNT
PMNT
49.5% more per $
PMNT
0.8%
-48.7%
CCEL
More free cash flow
PMNT
PMNT
$1.0M more FCF
PMNT
$2.2M
$1.2M
CCEL

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CCEL
CCEL
PMNT
PMNT
Revenue
$7.8M
$11.7M
Net Profit
$-3.8M
$93.0K
Gross Margin
77.9%
64.4%
Operating Margin
-50.6%
5.0%
Net Margin
-48.7%
0.8%
Revenue YoY
-2.3%
0.8%
Net Profit YoY
-105.1%
103.7%
EPS (diluted)
$-0.46
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
PMNT
PMNT
Q4 25
$7.8M
$11.7M
Q3 25
$7.8M
$4.8M
Q2 25
$7.9M
$1.5M
Q1 25
$8.0M
$5.0M
Q4 24
$8.0M
$11.7M
Q3 24
$8.1M
$3.8M
Q2 24
$8.0M
Q1 24
$7.9M
Net Profit
CCEL
CCEL
PMNT
PMNT
Q4 25
$-3.8M
$93.0K
Q3 25
$749.4K
$-1.8M
Q2 25
$355.8K
$-3.8M
Q1 25
$282.9K
$-7.3M
Q4 24
$-1.9M
$-2.5M
Q3 24
$1.1M
$-2.7M
Q2 24
$655.8K
Q1 24
$556.2K
Gross Margin
CCEL
CCEL
PMNT
PMNT
Q4 25
77.9%
64.4%
Q3 25
77.0%
60.1%
Q2 25
76.6%
60.4%
Q1 25
75.1%
32.0%
Q4 24
78.4%
54.8%
Q3 24
73.6%
54.0%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
PMNT
PMNT
Q4 25
-50.6%
5.0%
Q3 25
24.3%
-23.9%
Q2 25
18.8%
-207.5%
Q1 25
13.3%
-130.1%
Q4 24
-1.5%
-11.1%
Q3 24
17.2%
-66.7%
Q2 24
17.3%
Q1 24
10.5%
Net Margin
CCEL
CCEL
PMNT
PMNT
Q4 25
-48.7%
0.8%
Q3 25
9.6%
-38.6%
Q2 25
4.5%
-259.4%
Q1 25
3.5%
-145.5%
Q4 24
-23.2%
-21.3%
Q3 24
13.0%
-71.6%
Q2 24
8.2%
Q1 24
7.1%
EPS (diluted)
CCEL
CCEL
PMNT
PMNT
Q4 25
$-0.46
$0.00
Q3 25
$0.09
$-0.06
Q2 25
$0.04
$-0.21
Q1 25
$0.03
$-0.45
Q4 24
$-0.23
$-0.15
Q3 24
$0.13
$-0.17
Q2 24
$0.08
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
PMNT
PMNT
Cash + ST InvestmentsLiquidity on hand
$3.3M
$1.6M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$1.1M
Total Assets
$61.7M
$13.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
PMNT
PMNT
Q4 25
$3.3M
$1.6M
Q3 25
$3.2M
$393.0K
Q2 25
$4.4M
$3.0M
Q1 25
$3.5M
$6.2M
Q4 24
$3.5M
$2.8M
Q3 24
$2.1M
$725.0K
Q2 24
$1.5M
Q1 24
$979.6K
Total Debt
CCEL
CCEL
PMNT
PMNT
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
$1.9M
Q3 24
$8.5M
$1.8M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
PMNT
PMNT
Q4 25
$-18.6M
$1.1M
Q3 25
$-14.8M
$981.0K
Q2 25
$-15.6M
$987.0K
Q1 25
$-14.7M
$1.9M
Q4 24
$-13.2M
$907.0K
Q3 24
$-9.6M
$2.7M
Q2 24
$-10.7M
Q1 24
$-10.3M
Total Assets
CCEL
CCEL
PMNT
PMNT
Q4 25
$61.7M
$13.8M
Q3 25
$63.2M
$15.0M
Q2 25
$64.4M
$8.3M
Q1 25
$64.4M
$13.3M
Q4 24
$64.7M
$13.2M
Q3 24
$62.9M
$13.3M
Q2 24
$62.6M
Q1 24
$61.7M
Debt / Equity
CCEL
CCEL
PMNT
PMNT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
2.11×
Q3 24
0.67×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
PMNT
PMNT
Operating Cash FlowLast quarter
$1.3M
$2.3M
Free Cash FlowOCF − Capex
$1.2M
$2.2M
FCF MarginFCF / Revenue
15.5%
19.1%
Capex IntensityCapex / Revenue
0.9%
0.3%
Cash ConversionOCF / Net Profit
24.26×
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
PMNT
PMNT
Q4 25
$1.3M
$2.3M
Q3 25
$2.5M
$-7.2M
Q2 25
$707.0K
$-3.9M
Q1 25
$954.1K
$-1.1M
Q4 24
$2.2M
$-1.0M
Q3 24
$2.4M
$-3.9M
Q2 24
$1.8M
Q1 24
$-356.9K
Free Cash Flow
CCEL
CCEL
PMNT
PMNT
Q4 25
$1.2M
$2.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
$-1.1M
Q4 24
$2.1M
$-1.2M
Q3 24
$2.3M
$-3.9M
Q2 24
$21.5K
Q1 24
$-814.6K
FCF Margin
CCEL
CCEL
PMNT
PMNT
Q4 25
15.5%
19.1%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
-21.8%
Q4 24
26.8%
-10.6%
Q3 24
27.9%
-101.5%
Q2 24
0.3%
Q1 24
-10.4%
Capex Intensity
CCEL
CCEL
PMNT
PMNT
Q4 25
0.9%
0.3%
Q3 25
0.5%
Q2 25
0.8%
Q1 25
0.8%
0.3%
Q4 24
0.1%
1.6%
Q3 24
2.3%
1.0%
Q2 24
21.8%
Q1 24
5.8%
Cash Conversion
CCEL
CCEL
PMNT
PMNT
Q4 25
24.26×
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons